![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Z Abdel-Razzak, L Corcos, A Fautrel, JP Campion and A Guillouzo
INSERM U 49, Hopital de Pontchaillou, Rennes, France.
The effects of interleukin (IL)-1 beta, IL-4, IL-6, tumor necrosis factor (TNF)-alpha, interferon (IFN)-alpha, IFN-gamma, and transforming growth factor (TGF)-beta 1 on cytochrome P-450 (CYP) 1A expression and polycyclic aromatic hydrocarbon (PAH)-mediated induction in primary human hepatocyte cultures were determined. Most cytokines that were previously found to decrease basal CYP expression could counteract PAH induction of CYP1A mRNA and its associated ethoxyresorufin-O- deethylation (EROD) activity. IL-1 beta and TNF-alpha blocked 3- methylcholanthrene (3-MC)-induced EROD activity by up to 25 and 44%, respectively. IFN-alpha and IFN-gamma antagonized EROD induction by up to 61 and 70%, respectively. TGF-beta 1 proved to be the most effective cytokine, because 72 hr of treatment with 2 ng/ml TGF-beta 1 produced nearly 100% inhibition of 3-MC- and benzo(a)pyrene-induced CYP1A1 and CYP1A2 mRNAs and EROD activity. Treatment with cycloheximide in combination with 3-MC led to superinduction of CYP1A mRNA, under which conditions TGF-beta 1 did not block induction, suggesting the requirement for protein synthesis for the suppressive effect of the cytokine. In addition, TGF-beta 1 augmented AP-1-binding activity, suggesting that fos and/or jun protooncogene products could be implicated in the response. Our results demonstrate that IL-1 beta, TNF- alpha, and IFNs antagonized PAH-mediated induction of CYP1A gene expression in human hepatocytes. In addition, we report the finding of a novel effect of TGF-beta 1, which was able to prevent CYP1A1 and -1A2 induction by two different PAHs.
This article has been cited by other articles:
|
|
 |
|
  A. E. Aitken and E. T. Morgan Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes Drug Metab. Dispos., September 1, 2007; 35(9): 1687 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fradette, J. Batonga, S. Teng, M. Piquette-Miller, and P. du Souich Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver Drug Metab. Dispos., May 1, 2007; 35(5): 765 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Chung-Davidson, C. B. Rees, H. Wu, S.-S. Yun, and W. Li {beta}-naphthoflavone induction of CYP1A in brain of juvenile lake trout (Salvelinus namaycush Walbaum) J. Exp. Biol., April 1, 2004; 207(9): 1533 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Morel, N. Mermod, and R. Barouki An Autoregulatory Loop Controlling CYP1A1 Gene Expression: Role of H2O2 and NFI Mol. Cell. Biol., October 1, 1999; 19(10): 6825 - 6832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Morel and R. Barouki Down-regulation of Cytochrome P450 1A1 Gene Promoter by Oxidative Stress. CRITICAL CONTRIBUTION OF NUCLEAR FACTOR 1 J. Biol. Chem., October 9, 1998; 273(41): 26969 - 26976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Iber and E. T. Morgan Regulation of Hepatic Cytochrome P450 2C11 by Transforming Growth Factor-beta , Hepatocyte Growth Factor, and Interleukin-11 Drug Metab. Dispos., October 1, 1998; 26(10): 1042 - 1044. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. I. Guillén, M. T. Donato, R. Jover, J. V. Castell, R. Fabra, R. Trullenque, and M. J. Gómez-Lechón Oncostatin M Down-regulates Basal and Induced Cytochromes P450 in Human Hepatocytes J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 127 - 134. [Abstract] [Full Text]
|
|
|
|
|
|
M. T. Donato, M. J. Gómez-Lechón, R. Jover, T. Nakamura, and J. V. Castell Human Hepatocyte Growth Factor Down-regulates the Expression of Cytochrome P450 Isozymes in Human Hepatocytes in Primary Culture J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 760 - 767. [Abstract] [Full Text]
|
|
|
|
|
|
K. Maheo, J. Antras-Ferry, F. Morel, S. Langouet, and A. Guillouzo Modulation of Glutathione S-Transferase Subunits A2, M1, and P1 Expression by Interleukin-1beta in Rat Hepatocytes in Primary Culture J. Biol. Chem., June 27, 1997; 272(26): 16125 - 16132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Döhr, R. Sinning, C. Vogel, P. Münzel, and J. Abel Effect of Transforming Growth Factor-beta 1 on Expression of Aryl Hydrocarbon Receptor and Genes of Ah Gene Battery: Clues for Independent Down-Regulation in A549 Cells Mol. Pharmacol., May 1, 1997; 51(5): 703 - 710. [Abstract] [Full Text]
|
|
|
|
|
|
M. T. Donato, M. I. Guillén, R. Jover, J. V. Castell, and M. J. Gómez-Lechón Nitric Oxide-Mediated Inhibition of Cytochrome P450 by Interferon-gamma in Human Hepatocytes J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 484 - 490. [Abstract] [Full Text]
|
|
|
|
|
|
A.án. Sánchez, A. M. Alvarez, M. Benito, and I. Fabregat Apoptosis Induced by Transforming Growth Factor-beta in Fetal Hepatocyte Primary Cultures J. Biol. Chem., March 29, 1996; 271(13): 7416 - 7422. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
